Abstract
The aim of the current study was to evaluate a possible association between apolipoprotein E (ApoE) genetic polymorphisms and deep venous thrombosis. A case–control study of ApoE genetic polymorphisms was carried out in 60 male and female patients with deep venous thrombosis and 60 male and female controls. The ages of the patients ranged between 23 and 90 years old (mean ± standard deviation: 58 ± 16.56 years) and the ages of the control group, varied between 21 and 56 years old (mean ± SD: 33 ± 10.93 years). Genetic polymorphisms were analyzed in respect to the prevalence of alleles (APOE*2, APOE*3 and APOE*4) and genotypes (APOE*2/2, APOE*2/3, APOE*2/4, APOE*3/3, APOE*3/4 and APOE*4/4). The ε2 allele was more common in patients who had suffered thrombotic events (P = 0.0034). Additionally, there was a significant difference on comparing the distribution of alleles in female patients and female controls (P = 0.027). These results demonstrate an association between the ApoE ε2 allele and deep venous thrombotic events in women. This association opens the possibility of a new line of research to better understand these thrombotic events.
Similar content being viewed by others
References
Rihn BH, Berrahmoune S, Jouma M, Chamaa S, Marcocci L, Le Faou A (2009) APOE genotyping: comparison of three methods. Clin Exp Med 9(1):61–65
Ferreira CN, Carvalho MG, Fernandes AP, Lima LM, Loures-Valle AA, Dantas J, Janka Z, Palotás A, Sousa MO (2010) Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders. Neurochem Int 56(1):177–182
Olivieri O, Martinelli N, Girelli D, Pizzolo F, Friso S, Beltrame F, Lotto V, Annarumma L, Corrocher R (2010) Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation. J Thromb Haemost 8(3):463–471
Robertson JO, Li W, Silverstein RL, Topol EJ, Smith JD (2009) Deficiency of LRP8 in mice is associated with altered platelet function and prolonged time for in vivo thrombosis. Thromb Res 123(4):644–652
Goodman C, Goodman CS, Hur J, Jeyendran RS, Coulam C (2009) The association of Apoprotein E polymorphisms with recurrent pregnancy loss. Am J Reprod Immunol 61(1):34–38
Bock SC, Harris JF, Balazs I, trent JM (1985) Assignment of the human antithrombin III structural gene to chromosome 1q23-q25. Cytogenet Cell Genet 39:67
Dahlbäck B, Carlsson M, Svensson PJ (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90(3):1004–1008
Kohnke H, Sörlin K, Granath G, Wadelius M (2005) Warfarin dose related to apolipoprotein E (APOE) genotype. Eur J Clin Pharmacol 61(5–6):381–388
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nagato, L.C., de Souza Pinhel, M.A., de Godoy, J.M.P. et al. Association of ApoE genetic polymorphisms with proximal deep venous thrombosis. J Thromb Thrombolysis 33, 116–119 (2012). https://doi.org/10.1007/s11239-011-0639-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-011-0639-9